Enzymatic pathways of the brain renin-angiotensin system: Unsolved problems and continuing challenges

Regulatory Peptides

Volumn 143, Issue 1-3, 2007, Pages 15-27

  Karamyan, Vardan T ^a   Speth, Robert C ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Angiotensin receptors; Angiotensinases; Metabolism; Peptidases; Radioligand binding assays

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR; PEPTIDASE;

BRAIN; ENZYME ANALYSIS; HUMAN; ISOTOPE LABELING; NEUROCHEMISTRY; NEUROENDOCRINOLOGY; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSINS; ANIMALS; BRAIN; ENDOPEPTIDASES; HUMANS; MODELS, BIOLOGICAL; PEPTIDE HYDROLASES; RECEPTORS, ANGIOTENSIN; RENIN; SIGNAL TRANSDUCTION;

EID: 34547657601     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.03.006     Document Type: Review

References (173)

1. Bickerton R.K., and Buckley J.P. Evidence for a central mechanism in angiotensin induced hypertension. Proc Soc Exp Biol Med 106 (1961) 834-836
2. Booth D.A. Mechanism of action of norepinephrine in eliciting an eating response on injection into the rat hypothalamus. J Pharmacol Exp Ther 160 (1968) 336-348
3. Ganten D., Boucher R., and Genest J. Renin activity in brain tissue of puppies and adult dogs. Brain Res 33 (1971) 557-559
4. Severs W.B., and Daniels-Severs A.E. Effects of angiotensin on the central nervous system. Pharmacol Rev 25 (1973) 415-449
5. Phillips M.I. Angiotensin in the brain. Neuroendocrinology 25 (1978) 354-377
6. Unger T., Badoer E., Ganten D., Lang R.E., and Rettig R. Brain angiotensin: pathways and pharmacology. Circulation 77 (1988) I40-I54
7. Saavedra J.M. Brain and pituitary angiotensin. Endocr Rev 13 (1992) 329-380
8. Saavedra J.M. Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities. Cell Mol Neurobiol 25 (2005) 485-512
9. Wright J.W., and Harding J.W. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses. Neurosci Biobehav Rev 18 (1994) 21-53
10. Fitzsimons J.T. Angiotensin, thirst, and sodium appetite. Physiol Rev 78 (1998) 583-686
11. Phillips M.I., and Sumners C. Angiotensin II in central nervous system physiology. Regul Pept 78 (1998) 1-11
12. Speth R.C., Brown T.E., Barnes R.D., and Wright J.W. Brain angiotensinergic activity: the state of our current knowledge. Proc West Pharmacol Soc 46 (2003) 11-15
13. Hooper N.M. Proteases: a primer. Essays Biochem 38 (2002) 1-8
14. Albiston A.L., Ye S., and Chai S.Y. Membrane bound members of the M1 family: more than aminopeptidases. Protein Pept Lett 11 (2004) 491-500
15. Lew R.A. The zinc metallopeptidase family: new faces, new functions. Protein Pept Lett 11 (2004) 407-414
16. Regoli D., Riniker B., and Brunner H. The enzymatic degradation of various angiotensin II derivatives by serum, plasma or kidney homogenate. Biochem Pharmacol 12 (1963) 637-646
17. Tigerstedt R., and Bergmann P.G. Niere und kreislauf. Scand Arch Physiol 8 (1898) 223-271
18. Sernia C. Location and secretion of brain angiotensinogen. Regul Pept 57 (1995) 1-18
19. Skeggs Jr. L.T., Kahn J.R., Lentz K., and Shumway N.P. The preparation, purification, and amino acid sequence of a polypeptide renin substrate. J Exp Med 106 (1957) 439-453
20. Peach M.J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 57 (1977) 313-370
21. Dzau V.J., Brenner A., and Emmett N.L. Evidence for renin in rat brain: differentiation from other reninlike enzymes. Am J Physiol 242 (1982) E292-E297
22. Morris B.J. Molecular biology of renin. I: Gene and protein structure, synthesis and processing. J Hypertens 10 (1992) 209-214
23. Lee-Kirsch M.A., Gaudet F., Cardoso M.C., and Lindpaintner K. Distinct renin isoforms generated by tissue-specific transcription initiation and alternative splicing. Circ Res 84 (1999) 240-246
24. Sinn P.L., and Sigmund C.D. Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation. Physiol Genomics 3 (2000) 25-31
25. Lavoie J.L., Cassell M.D., Gross K.W., and Sigmund C.D. Adjacent expression of renin and angiotensinogen in the rostral ventrolateral medulla using a dual-reporter transgenic model. Hypertension 43 (2004) 1116-1119
26. Lavoie J.L., Liu X., Bianco R.A., Beltz T.G., Johnson A.K., and Sigmund C.D. Evidence supporting a functional role for intracellular renin in the brain. Hypertension 47 (2006) 461-466
27. Day RPReid IA. Renin activity in dog brain: enzymological similarity to cathepsin D. Endocrinology 99 (1976) 93-100
28. Hackenthal E., Hackenthal R., and Hilgenfeldt U. Isorenin, pseudorenin, cathepsin D and renin. A comparative enzymatic study of angiotensin-forming enzymes. Biochim Biophys Acta 522 (1978) 574-588
29. Kageyama T., Ichinose M., and Yonezawa S. Processing of the precursors to neurotensin and other bioactive peptides by cathepsin E. J Biol Chem 270 (1995) 19135-19140
30. Nakanishi H., and Yamamoto K. Cathepsin E in the central nervous system. Adv Exp Med Biol 436 (1998) 213-217
31. Davies B.J., Pickard B.S., Steel M., Morris R.G., and Lathe R. Serine proteases in rodent hippocampus. J Biol Chem 273 (1998) 23004-23011
32. Ramaha A., and Patston P.A. Release and degradation of angiotensin I and angiotensin II from angiotensinogen by neutrophil serine proteinases. Arch Biochem Biophys 397 (2002) 77-83
33. Grise C., Boucher R., Thibault G., and Genest J. Formation of angiotensin II by tonin from partially purified human angiotensinogen. Can J Biochem 59 (1981) 250-255
34. Abraham C.R., Kanemaru K., and Mucke L. Expression of cathepsin G-like and alpha 1-antichymotrypsin-like proteins in reactive astrocytes. Brain Res 621 (1993) 222-232
35. Savage M.J., Iqbal M., Loh T., Trusko S.P., Scott R., and Siman R. Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein. Neuroscience 60 (1994) 607-619
36. Lopes E.S., Sumitani M., Juliano L., Beraldo W.T., and Pesquero J.L. Distribution of tonin- and kallikrein-like activities in rat brain. Brain Res 769 (1997) 152-157
37. Araujo R.C., Lima M.P., Lomez E.S., Bader M., Pesquero J.B., Sumitani M., and Pesquero J.L. Tonin expression in the rat brain and tonin-mediated central production of angiotensin II. Physiol Behav 76 (2002) 327-333
38. Garcia D.R., Smellie W.S., and Morton J.J. des-Asp-angiotensin I: its identification in rat blood and confirmation as a substrate for converting enzyme. Endocrinology 108 (1981) 406-412
39. Chappell M.C., Pirro N.T., Sykes A., and Ferrario C.M. Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme. Hypertension 31 (1998) 362-367
40. Skidgel R.A., and Erdos E.G. Angiotensin converting enzyme (ACE) and neprilysin hydrolyze neuropeptides: a brief history, the beginning and follow-ups to early studies. Peptides 25 (2004) 521-525
41. Guy J.L., Lambert D.W., Warner F.J., Hooper N.M., and Turner A.J. Membrane-associated zinc peptidase families: comparing ACE and ACE2. Biochim Biophys Acta 1751 (2005) 2-8
42. Pagliaro PPenna C. Rethinking the renin-angiotensin system and its role in cardiovascular regulation. Cardiovasc Drugs Ther 19 (2005) 77-87
43. Rice G.I., Thomas D.A., Grant P.J., Turner A.J., and Hooper N.M. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383 (2004) 45-51
44. Corvol P., Michaud A., Soubrier F., and Williams T.A. Recent advances in knowledge of the structure and function of the angiotensin I converting enzyme. J Hypertension 13 (1995) S3-S10
45. Erdos E.G., and Skidgel R.A. Renal metabolism of angiotensin I and II. Kidney Inter Suppl 30 (1990) S24-S27
46. Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., Acton S., Patane M., Nichols A., and Tummino P. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277 (2002) 14838-14843
47. Sleat D.E., Sohar I., Lackland H., Majercak J., and Lobel P. Rat brain contains high levels of mannose-6-phosphorylated glycoproteins including lysosomal enzymes and palmitoyl-protein thioesterase, an enzyme implicated in infantile neuronal lipofuscinosis. J Biol Chem 271 (1996) 19191-19198
48. Hiraiwa M. Cathepsin A/protective protein: an unusual lysosomal multifunctional protein. Cell Mol Life Sci 56 (1999) 894-907
49. Sohma O., Mizuguchi M., Takashima S., Satake A., Itoh K., Sakuraba H., Suzuki Y., and Oyanagi K. Expression of protective protein in human tissue. Pediatr Neurol 20 (1999) 210-214
50. Galjart N.J., Morreau H., Willemsen R., Gillemans N., Bonten E.J., and d'Azzo A. Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function. J Biol Chem 266 (1991) 14754-14762
51. Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., and Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275 (2000) 33238-33243
52. Li W., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., and Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426 (2003) 450-454
53. Turner A.J., Hiscox J.A., and Hooper N.M. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci 25 (2004) 291-294
54. Azaryan A., Barkhudaryan N., Galoyan A., and Lajtha A. Action of brain cathepsin B, cathepsin D, and high-molecular-weight aspartic proteinase on angiotensins I and II. Neurochem Res 10 (1985) 1525-1532
55. Stoka V., Turk B., and Turk V. Lysosomal cysteine proteases: structural features and their role in apoptosis. IUBMB Life 57 (2005) 347-353
56. Bacani CFrishman W.H. Chymase: a new pharmacologic target in cardiovascular disease. Cardiol Rev 14 (2006) 187-193
57. Baltatu O., Nishimura H., Hoffmann S., Stoltenburg G., Haulica I.D., Lippoldt A., Ganten D., and Urata H. High levels of human chymase expression in the pineal and pituitary glands. Brain Res 752 (1997) 269-278
58. Tonnaer J.A., Engels G.M., Wiegant V.M., Burbach J.P., De Jong W., and De Wied D. Proteolytic conversion of angiotensins in rat brain tissue. Eur J Biochem 131 (1983) 415-421
59. Bausback H.H., Churchill L., and Ward P.E. Angiotensin metabolism by cerebral microvascular aminopeptidase A. Biochem Pharmacol 37 (1988) 155-160
60. Hermann K., Phillips M.I., and Raizada M.K. Metabolism of angiotensin peptides by neuronal and glial cultures from rat brain. J Neurochem 52 (1989) 863-868
61. Swanson G.N., Hanesworth J.M., Sardinia M.F., Coleman J.K., Wright J.W., Hall K.L., Miller-Wing A.V., Stobb J.W., Cook V.I., and Harding E.C. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor. Regul Pept 40 (1992) 409-419
62. Wright J.W., and Harding J.W. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Prog Neurobiol 72 (2004) 263-293
63. Reaux A., Iturrioz X., Vazeux G., Fournie-Zaluski M.C., David C., Roques B.P., Corvol P., and Llorens-Cortes C. Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in central control of arterial blood pressure. Biochem Soc Trans 28 (2000) 435-440
64. Wilson W.L., Roques B.P., Llorens-Cortes C., Speth R.C., Harding J.W., and Wright J.W. Roles of brain angiotensins II and III in thirst and sodium appetite. Brain Res 1060 (2005) 108-117
65. Kokje RJ, Wilson WL, Brown TE, Karamyan VT, Wright JW, Speth RC. Pressor Actions of Aminopeptidase-Resistant Analogs of Angiotensin II in the Rat Brain: Challenging the Angiotensin III Hypothesis. Hypertension (in press).
66. Sim M.K., Choo M.H., and Qiu X.S. Degradation of angiotensin I to [des-Asp1]angiotensin I by a novel aminopeptidase in the rat hypothalamus. Biochem Pharmacol 48 (1994) 1043-1046
67. Wilk S., Wilk E., and Magnusson R.P. Purification, characterization, and cloning of a cytosolic aspartyl aminopeptidase. J Biol Chem 273 (1998) 15961-15970
68. Ofner L.D., and Hooper N.M. The C-terminal domain, but not the interchain disulphide, is required for the activity and intracellular trafficking of aminopeptidase A. Biochem J 362 (2002) 191-197
69. Healy D.P., and Wilk S. Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II. Brain Res 606 (1993) 295-303
70. Migaud M., Durieux C., Viereck J., Soroca-Lucas E., Fournie-Zaluski M.C., and Roques B.P. The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A. Peptides 17 (1996) 601-607
71. Schomburg L., Kollmus H., Friedrichsen S., and Bauer K. Molecular characterization of a puromycin-insensitive leucyl-specific aminopeptidase, PILS-AP. Eur J Biochem 267 (2000) 3198-3207
72. Tsujimoto M., and Hattori A. The oxytocinase subfamily of M1 aminopeptidases. Biochim Biophys Acta 1751 (2005) 9-18
73. Hattori A., Kitatani K., Matsumoto H., Miyazawa S., Rogi T., Tsuruoka N., Mizutani S., Natori Y., and Tsujimoto M. Characterization of recombinant human adipocyte-derived leucine aminopeptidase expressed in Chinese hamster ovary cells. J Biochem (Tokyo) 128 (2000) 755-762
74. Albiston A.L., McDowall S.G., Matsacos D., Sim P., Clune E., Mustafa T., Lee J., Mendelsohn F.A., Simpson R.J., Connolly L.M., and Chai S.Y. Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J Biol Chem 276 (2001) 48623-48626
75. Sim M.K., and Lim B.C. Determination of aminopeptidase X activity in tissues of normo- and hypertensive rats by capillary electrophoresis. J Chromatogr B Biomed Sci Appl 697 (1997) 259-262
76. Kelly J.A., Neidle E.L., and Neidle A. An aminopeptidase from mouse brain cytosol that cleaves N-terminal acidic amino acid residues. J Neurochem 40 (1983) 1727-1734
77. Harding J.W., Yoshida M.S., Dilts R.P., Woods T.M., and Wright J.W. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat. J Neurochem 46 (1986) 1292-1297
78. Wright J.W., Bechtholt A.J., Chambers S.L., and Harding J.W. Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function. Peptides 17 (1996) 1365-1371
79. Goto Y., Hattori A., Ishii Y., Mizutani S., and Tsujimoto M. Enzymatic properties of human aminopeptidase A. Regulation of its enzymatic activity by calcium and angiotensin IV. J Biol Chem 281 (2006) 23503-23513
80. Sim M.K., and Min L. Des-aspartate-angiotensin I and angiotensin AT1 receptors in rat cardiac ventricles. Regul Pept 129 (2005) 133-137
81. Tsujimoto M., Mizutani S., Adachi H., Kimura M., Nakazato H., and Tomoda Y. Identification of human placental leucine aminopeptidase as oxytocinase. Arch Biochem Biophys 292 (1992) 388-392
82. Tanioka T., Hattori A., Masuda S., Nomura Y., Nakayama H., Mizutani S., and Tsujimoto M. Human leukocyte-derived arginine aminopeptidase. The third member of the oxytocinase subfamily of aminopeptidases. J Biol Chem 278 (2003) 32275-32283
83. Reaux A., de Mota N., Zini S., Cadel S., Fournie-Zaluski M.C., Roques B.P., Corvol P., and Llorens-Cortes C. PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III. Neuroendocrinology 69 (1999) 370-376
84. Bauvois B., and Dauzonne D. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects. Med Res Rev 26 (2006) 88-130
85. Chansel D., Czekalski S., Vandermeersch S., Ruffet E., Fournie-Zaluski M.C., and Ardaillou R. Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells. Am J Physiol 275 (1998) F535-F542
86. Ramirez M., Arechaga G., Garcia S., Sanchez B., Lardelli P., and Gandarias J.M. Soluble and membrane-bound leucyl- and arginyl-aminopeptidase activities in subcellular fractions of young and adult rat brains. Rev Esp Fisiol 46 (1990) 393-397
87. Foulon T., Cadel S., and Cohen P. Aminopeptidase B (EC 3.4.11.6). Int J Biochem Cell Biol 31 (1999) 747-750
88. Zini S., Fournie-Zaluski M.C., Chauvel E., Roques B.P., Corvol P., and Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc Natl Acad Sci U S A 93 (1996) 11968-11973
89. Reaux A., Fournie-Zaluski M.C., David C., Zini S., Roques B.P., Corvol P., and Llorens-Cortes C. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci U S A 96 (1999) 13415-13420
90. Lee C.M., and Snyder S.H. Dipeptidyl-aminopeptidase III of rat brain. Selective affinity for enkephalin and angiotensin. J Biol Chem 257 (1982) 12043-12050
91. Alba F., Arenas J.C., and Lopez M.A. Properties of rat brain dipeptidyl aminopeptidases in the presence of detergents. Peptides 16 (1995) 325-329
92. Smyth MO'Cuinn G. Dipeptidyl aminopeptidase III of guinea-pig brain: specificity for short oligopeptide sequences. J Neurochem 63 (1994) 1439-1445
93. Gafford J.T., Skidgel R.A., Erdos E.G., and Hersh L.B. Human kidney "enkephalinase", a neutral metalloendopeptidase that cleaves active peptides. Biochemistry 22 (1983) 3265-3271
94. Dahms P., and Mentlein R. Purification of the main somatostatin-degrading proteases from rat and pig brains, their action on other neuropeptides, and their identification as endopeptidases 24.15 and 24.16. Eur J Biochem 208 (1992) 145-154
95. Shivakumar B.R., Wang Z., Hammond T.G., and Harris R.C. EP24.15 interacts with the angiotensin II type I receptor and bradykinin B2 receptor. Cell Biochem Funct 23 (2005) 195-204
96. Welches W.R., Santos R.A., Chappell M.C., Brosnihan K.B., Greene L.J., and Ferrario C.M. Evidence that prolyl endopeptidase participates in the processing of brain angiotensin. J Hypertens 9 (1991) 631-638
97. O'Leary R.M., Gallagher S.P., and O'Connor B. Purification and characterization of a novel membrane-bound form of prolyl endopeptidase from bovine brain. Int J Biochem Cell Biol 28 (1996) 441-449
98. McDermott J.R., Gibson A.M., and Turner J.D. Involvement of endopeptidase 24.15 in the inactivation of bradykinin by rat brain slices. Biochem Biophys Res Commun 146 (1987) 154-158
99. Welches W.R., Brosnihan K.B., and Ferrario C.M. A comparison of the properties and enzymatic activities of three angiotensin processing enzymes: angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci 52 (1993) 1461-1480
100. Rioli V., Kato A., Portaro F.C., Cury G.K., te K.K., Vincent B., Checler F., Camargo A.C., Glucksman M.J., Roberts J.L., Hirose S., and Ferro E.S. Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15. Biochem Biophys Res Commun 250 (1998) 5-11
101. Schiavone M.T., Santos R.A., Brosnihan K.B., Khosla M.C., and Ferrario C.M. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci U S A 85 (1988) 4095-4098
102. Ferrario C.M., and Chappell M.C. Novel angiotensin peptides. Cell Mol Life Sci 61 (2004) 2720-2727
103. Santos R.A., Simoes e Silva A.C., Maric C., Silva D.M., Machado R.P., de I B., Heringer-Walther S., Pinheiro S.V., Lopes M.T., Bader M., Mendes E.P., Lemos V.S., Campagnole-Santos M.J., Schultheiss H.P., Speth R., and Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci U S A 100 (2003) 8258-8263
104. Hellner K., Walther T., Schubert M., and Albrecht D. Angiotensin-(1-7) enhances LTP in the hippocampus through the G-protein-coupled receptor Mas. Mol Cell Neurosci 29 (2005) 427-435
105. Roques B.P., Noble F., Dauge V., Fournie-Zaluski M.C., and Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45 (1993) 87-146
106. Turner A.J., and Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 11 (1997) 355-364
107. Abhold R.H., and Harding J.W. Metabolism of angiotensins II and III by membrane-bound peptidases from rat brain. J Pharmacol Exp Ther 245 (1988) 171-177
108. Allred A.J., Diz D.I., Ferrario C.M., and Chappell M.C. Pathways for angiotensin-(1-7) metabolism in pulmonary and renal tissues. Am J Physiol Renal Physiol 279 (2000) F841-F850
109. Dauch P., Vincent J.P., and Checler F. Molecular cloning and expression of rat brain endopeptidase 3.4.24.16. J Biol Chem 270 (1995) 27266-27271
110. Ferro E.S., Carreno F.R., Goni C., Garrido P.A., Guimaraes A.O., Castro L.M., Oliveira V., Araujo M.C., Rioli V., Gomes M.D., Fontenele-Neto J.D., and Hyslop S. The intracellular distribution and secretion of endopeptidases 24.15 (EC 3.4.24.15) and 24.16 (EC 3.4.24.16). Protein Pept Lett 11 (2004) 415-421
111. Chu T.G., and Orlowski M. Soluble metalloendopeptidase from rat brain: action on enkephalin-containing peptides and other bioactive peptides. Endocrinology 116 (1985) 1418-1425
112. Acker G.R., Molineaux C., and Orlowski M. Synaptosomal membrane-bound form of endopeptidase-24.15 generates Leu-enkephalin from dynorphin1-8, alpha- and beta-neoendorphin, and Met-enkephalin from Met-enkephalin-Arg6-Gly7-Leu8. J Neurochem 48 (1987) 284-292
113. Healy D.P., and Orlowski M. Immunocytochemical localization of endopeptidase 24.15 in rat brain. Brain Res 571 (1992) 121-128
114. Fontenele-Neto J.D., Massarelli E.E., Gurgel Garrido P.A., Beaudet A., and Ferro E.S. Comparative fine structural distribution of endopeptidase 24.15 (EC3.4.24.15) and 24.16 (EC3.4.24.16) in rat brain. J Comp Neurol 438 (2001) 399-410
115. Vincent B., Beaudet A., Dauch P., Vincent J.P., and Checler F. Distinct properties of neuronal and astrocytic endopeptidase 3.4.24.16: a study on differentiation, subcellular distribution, and secretion processes. J Neurosci 16 (1996) 5049-5059
116. Polgar L. The prolyl oligopeptidase family. Cell Mol Life Sci 59 (2002) 349-362
117. Rosenblum J.S., and Kozarich J.W. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery. Curr Opin Chem Biol 7 (2003) 496-504
118. Andrews P.C., Hines C.M., and Dixon J.E. Characterization of proline endopeptidase from rat brain. Biochemistry 19 (1980) 5494-5500
119. Fruitier-Arnaudin I., Cohen M., Coitoux C., and Piot J.M. In vitro metabolism of LVV-Hemorphin-7 by renal cytosol and purified prolyl endopeptidase. Peptides 24 (2003) 1201-1206
120. Walter R., Simmons W.H., and Yoshimoto T. Proline specific endo- and exopeptidases. Mol Cell Biochem 30 (1980) 111-127
121. Wilk S. Prolyl endopeptidase. Life Sci 33 (1983) 2149-2157
122. Odya C.E., Marinkovic D.V., Hammon K.J., Stewart T.A., and Erdos E.G. Purification and properties of prolylcarboxypeptidase (angiotensinase C) from human kidney. J Biol Chem 253 (1978) 5927-5931
123. Orawski A.T., and Simmons W.H. Degradation of bradykinin and its metabolites by rat brain synaptic membranes. Peptides 10 (1989) 1063-1073
124. Tan F., Morris P.W., Skidgel R.A., and Erdos E.G. Sequencing and cloning of human prolylcarboxypeptidase (angiotensinase C). Similarity to both serine carboxypeptidase and prolylendopeptidase families. J Biol Chem 268 (1993) 16631-16638
125. Moreira C.R., Schmaier A.H., Mahdi F., da Motta G., Nader H.B., and Shariat-Madar Z. Identification of prolylcarboxypeptidase as the cell matrix-associated prekallikrein activator. FEBS Lett 523 (2002) 167-170
126. Skidgel R.A., and Erdos E.G. Cellular carboxypeptidases. Immunol Rev 161 (1998) 129-141
127. Glossmann H., Baukal A.J., and Catt K.J. Properties of angiotensin II receptors in the bovine and rat adrenal cortex. J Biol Chem 249 (1974) 825-834
128. Bennett Jr. J.P., and Snyder S.H. Angiotensin II binding to mammalian brain membranes. J Biol Chem 251 (1976) 7423-7430
129. Sirett N.E., McLean A.S., Bray J.J., and Hubbard J.I. Distribution of angiotensin II receptors in rat brain. Brain Res 122 (1977) 299-312
130. Cole F.E., Blakesley H.L., Graci K.A., Frohlich E.D., and MacPhee A.A. Brain angiotensin II receptor affinity and capacity in SHR and WKY rats: effects of acute dietary changes in NaCl. Brain Res 190 (1980) 272-277
131. Harding J.W., Stone L.P., and Wright J.W. The distribution of angiotensin II binding sites in rodent brain. Brain Res 205 (1981) 265-274
132. Chen F.M., Hawkins R., and Printz M.P. Evidence for a functional, independent brain-angiotensin system: correlation between regional distribution of brain angiotensin receptors, brain angiotensin and drinking during the estrous cycle of rats. Exp Brain Res Suppl 40 (1982) 157-168
133. Petersen E.P., Camara C.G., Abhold R.H., Wright J.W., and Harding J.W. Characterization of angiotensin binding to gerbil brain membranes using [125I]angiotensin III as the radioligand. Brain Res 321 (1984) 225-235
134. Petersen E.P., Abhold R.H., Camara C.G., Wright J.W., and Harding J.W. Characterization of angiotensin binding in the African green monkey. Brain Res 341 (1985) 139-146
135. Speth R.C., Wamsley J.K., Gehlert D.R., Chernicky C.L., Barnes K.L., and Ferrario C.M. Angiotensin II receptor localization in the canine CNS. Brain Res 326 (1985) 137-143
136. Printz M.P., Chen F.M., Slivka S., and Maciejewski A.R. Comparison of neural and peripheral angiotensin II receptors. In: Buckley J.P., and Ferrario C.M. (Eds). Brain Peptides and Catecholamines in Cardiovascular Regulation (1987), Raven Press, New York 233-243
137. Gehlert D.R., Speth R.C., Healy D.P., and Wamsley J.K. Autoradiographic localization of angiotensin II receptors in the rat brainstem. Life Sci 34 (1984) 1565-1571
138. Gehlert D.R., Speth R.C., and Wamsley J.K. Autoradiographic localization of angiotensin II receptors in the rat brain and kidney. Eur J Pharmacol 98 (1984) 145-146
139. Mendelsohn F.A., Quirion R., Saavedra J.M., Aguilera G., and Catt K.J. Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci U S A 81 (1984) 1575-1579
140. Hwang B.H., Harding J.W., Liu D.K., Hibbard L.S., Wieczorek C.M., and Wu J.Y. Quantitative autoradiography of 125I-[Sar1, Ile8]-angiotensin II binding in the brain of spontaneously hypertensive rats. Brain Res Bull 16 (1986) 75-82
141. Rowe B.P., Saylor D.L., and Speth R.C. Novel angiotensin II binding sites in the mesopontine area of the rat brain. Brain Res 534 (1990) 129-134
142. Harding J.W., Erickson J.B., Camara C.C., Abhold R.H., and Wright J.W. High-performance liquid chromatographic analysis of 'specifically bound' label after [125I]angiotensin II binding to rat brain membranes. Neurosci Lett 65 (1986) 23-28
143. Abhold R.H., Sullivan M.J., Wright J.W., and Harding J.W. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin. J Pharmacol Exp Ther 242 (1987) 957-962
144. Bennett Jr. J.P., and Snyder S.H. Receptor binding interactions of the angiotensin II antagonist, 125I-[sarcosine1,leucine8]angiotensin II, with mammalian brain and peripheral tissues. Eur J Pharmacol 67 (1980) 11-25
145. Ellis S., and Nuenke J.M. Dipeptidyl arylamidase III of the pituitary. Purification and characterization. J Biol Chem 242 (1967) 4623-4629
146. Dando P.M., Brown M.A., and Barrett A.J. Human thimet oligopeptidase. Biochem J 294 2 (1993) 451-457
147. Shrimpton C.N., Glucksman M.J., Lew R.A., Tullai J.W., Margulies E.H., Roberts J.L., and Smith A.I. Thiol activation of endopeptidase EC 3.4.24.15. A novel mechanism for the regulation of catalytic activity. J Biol Chem 272 (1997) 17395-17399
148. Grover A.K., Kwan C.Y., Kostka P., and Daniel E.E. Binding and degradation of angiotensin II by mesenteric artery subcellular membranes. Eur J Pharmacol 112 (1985) 137-143
149. Wang J.M., Baudhuin P., Courtoy P.J., and de Potter W. Conversion of angiotensin II into active fragments by an endosomal pathway in bovine adrenal medullary cells in primary culture. Endocrinology 136 (1995) 5274-5282
150. Mendelsohn F.A., Aguilera G., Saavedra J.M., Quirion R., and Catt K.J. Characteristics and regulation of angiotensin II receptors in pituitary, circumventricular organs and kidney. Clin Exp Hypertens Part A Theory Pract 5 (1983) 1081-1097
151. Israel A., Plunkett L.M., and Saavedra J.M. Quantitative autoradiographic characterization of receptors for angiotensin II and other neuropeptides in individual brain nuclei and peripheral tissues from single rats. Cell Mol Neurobiol 5 (1985) 211-222
152. Speth R.C., Bumpus F.M., and Husain A. Identification of angiotensin II receptors in the rat ovary. Eur J Pharmacol 130 (1986) 351-352
153. Marshall G.R., Vine W., and Needlemann P. A specific competitive inhibitor of angiotensin II. Proc Natl Acad Sci U S A 67 (1970) 1624-1630
154. Khairallah P.A., Toth A., and Bumpus F.M. Analogs of angiotensin II. II. Mechanism of receptor interaction. J Med Chem 13 (1970) 181-184
155. Noda K., Saad Y., and Karnik S.S. Interaction of Phe(8) of angiotensin II with Lys(199) and His(256) of AT(1) receptor in agonist activation. J Biol Chem 270 (1995) 28511-28514
156. Rodbell M., Krans H.M., Pohl S.L., and Birnbaumer L. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon. J Biol Chem 246 (1971) 1872-1876
157. Crane J.K., Campanile C.P., and Garrison J.C. The hepatic angiotensin II receptor II. Effect of guanine nucleotides and interaction with cyclic AMP production. J Biol Chem 257 (1982) 4959-4965
158. Speth R.C., and Kim K.H. Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II. Biochem. Biophys Res Commun 169 (1990) 997-1006
159. Mukoyama M., Horiuchi M., Nakajima M., Pratt R.E., and Dzau V.J. Characterization of a rat type 2 angiotensin II receptor stably expressed in 293 cells. Mol Cell Endocrinol 112 (1995) 61-68
160. Ouali R., LeBrethon M.C., and Saez J.M. Identification and characterization of angiotensin-II receptor subtypes in cultured bovine and human adrenal fasciculata cells and PC12W cells. Endocrinology 133 (1993) 2766-2772
161. Regoli D., Rioux F., Park W.K., and Choi C. Role of the N-terminal amino acid for the biological activities of angiotensin and inhibitory analogues. Can J Physiol Pharm 52 (1974) 39-49
162. Gunther S., Gimbrone Jr. M.A., and Alexander R.W. Identification and characterization of the high affinity vascular angiotensin II receptor in rat mesenteric artery. Circ Res 47 (1980) 278-286
163. Gunther S. Characterization of angiotensin II receptor subtypes in rat liver. J Biol Chem 259 (1984) 7622-7629
164. Whitebread S., Mele M., Kamber B., and de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 163 (1989) 284-291
165. Chiu A.T., McCall D.E., Nguyen T.T., Carini D.J., Duncia J.V., Herblin W.F., Uyeda R.T., Wong P.C., Wexler R.R., and Johnson A.L. Discrimination of angiotensin II receptor subtypes by dithiothreitol. Eur J Pharmacol 170 (1989) 117-118
166. Speth R.C., Rowe B.P., Grove K.L., Carter M.R., and Saylor D. Sulfhydryl reducing agents distinguish two subtypes of angiotensin II receptors in the rat brain. Brain Res 548 (1991) 1-8
167. Gehlert D.R., Gackenheimer S.L., and Schober D.A. Angiotensin II receptor subtypes in rat brain: dithiothreitol inhibits ligand binding to AII-1 and enhances binding to AII-2. Brain Res 546 (1991) 161-165
168. Karamyan VT, Gadepalli R, Rimoldi J, Speth RC. Preservation of 125-I-Angiotensin II in brain AT-1 receptor binding assays. 2007 Experimental Biology meeting abstracts [on CD-ROM], Abstract #571.3.
169. Karamyan V., and Speth R. Identification of a novel non-AT1, non-AT2 angiotensin binding site in the rat brain. Brain Res 1143 (2007) 83-91
170. Rawlings N.D., Morton F.R., and Barrett A.J. MEROPS: the peptidase database. Nucleic Acids Res 34 (2006) D270-D272
171. Kugler P. Aminopeptidase A is angiotensinase A. II. Biochemical studies on aminopeptidase A and M in rat kidney homogenate. Histochemistry 74 (1982) 247-261
172. Sakura H., Kobayashi H., Mizutani S., Sakura N., Hashimoto T., and Kawashima Y. Kinetic properties of placental aminopeptidase A: N-terminal degradation of angiotensin II. Biochem Int 6 (1983) 609-615
173. Palmieri F.E., Bausback H.H., and Ward P.E. Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M. Biochem Pharmacol 38 (1989) 173-180